Breaking News
Investing Pro 0
Donate to earthquake relief efforts in Turkey and Syria Donate

Chart Of The Day: After Pfizer's Paxlovid Fails Trial, Where Next For The Stock?

By Investing.com (Pinchas Cohen/Investing.com)Stock MarketsMay 03, 2022 09:29AM ET
www.investing.com/analysis/chart-of-the-day-after-pfizers-paxlovid-fails-trial-where-next-for-the-stock-200623370
Chart Of The Day: After Pfizer's Paxlovid Fails Trial, Where Next For The Stock?
By Investing.com (Pinchas Cohen/Investing.com)   |  May 03, 2022 09:29AM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
 
PFE
+0.91%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 

Shares of Pfizer (NYSE:PFE) headed lower on Monday, after the pharmaceuticals giant announced on Friday that its coronavirus drug, Paxlovid, failed a late-stage trial when it didn't "meet its primary goal of significantly reducing the risk of COVID-19 infection in adults exposed to the virus."

Investors sold off Pfizer stock on Friday in after hours trading. Shares fell as much as 3.9% before the weekend. And though PFE stock gapped lower by 3% at the open on Monday, the stock found support during the day which cut the falling gap by 1.5% at the close.

So, with the viral outbreak slowing in many countries and its newest anti-viral treatment stalled, is it inevitable that Pfizer shares are heading lower? Not necessarily.

Some researchers are making a case for Paxlovid as a treatment for long COVID which is estimated to affect about 30% of those who were infected with the virus. As well, health analytics firm Airfinity forecasts that Paxlovid could be one of the fastest selling treatments for COVID. Airfinity analysts expect revenues of nearly $24 billion from the treatment in 2022.

With seemingly conflicting fundamentals, is PFE a buying opportunity, or a stock headed for a crash? The balance of supply and demand is telling a mixed story.

PFE Daily
PFE Daily

Even before the company's announcement on Friday about the failed Paxlovid trial, the stock had already completed an Evening Star. The pattern consists of three candles demonstrating a reversal after a bullish push in the form of a long green candle. A follow-up rising gap was pushed back by bears via a falling gap, followed by a long red candle. This pattern's bearish sentiment was reinforced by a second gap.

The Evening Star confirmed the resistance of a double-top, whose neckline is reinforced by the 50 DMA, foretold by diminishing volume, providing a negative correlation between falling momentum as measured by the Rate of Change to the rising price between the Mar. 21 and Apr. 11 peaks.

Still, the price found support when it bounced off a rising trendline. The longer view provides some context for this trendline.

PFE Weekly
PFE Weekly

Via the bigger picture, the rising trendline may be a honeytrap in the form of an upward sloping H&S top, again reinforced by the 50 WMA.

The weakening momentum, represented by the Relative Strength Index, did not support the rising price between the August and December peaks, triggering a Negative Divergence. Similarly, the RSI diverged from the increasing price troughs from October 2021 to February 2022.

So, based on all the evidence, the double-top on the daily chart, confirmed by the Evening Star's implied target, would complete the weekly H&S top by crossing below its neckline.

However, beware of whipsaws. Note that the weekly RSI may find support by its recent lows and rise again, even if the price ultimately heads lower. Therefore, a trading strategy coupled with money management tailored to individual needs is essential for success.

Trading Strategies

Conservative traders should wait for the weekly H&S to complete with a downside breakout below the February lows, followed by a return move that demonstrates distribution.

Moderate traders would wait for the price to slip to $46, then remain below the neckline for two sessions. They might then wait for a corrective rally for a better entry.

Aggressive traders could enter a long contrarian position now, hoping for a rebound off the rising trend line and taking advantage of its proximity, before returning for short amid a return move to retest the Evening Star.

Trade Sample – Aggressive Long Position

  • Entry: $47.50
  • Stop-Loss: $47
  • Risk: $0.50
  • Target: $50.00
  • Reward: $2.50
  • Risk-Reward Ratio: 1:5

Trade Sample Follow-Up – Aggressive Short

  • Entry: $50.25
  • Stop-Loss: $51.00
  • Risk: $0.75
  • Target: $48.00
  • Reward: $2.25
  • Risk-Reward Ratio: 1:3
Chart Of The Day: After Pfizer's Paxlovid Fails Trial, Where Next For The Stock?
 

Related Articles

Chart Of The Day: After Pfizer's Paxlovid Fails Trial, Where Next For The Stock?

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email